Another Step Forward in Cell Reprogramming
HarvardScience “Chemical used in place of two cancer genes in reprogramming process” Read more »
HarvardScience “Chemical used in place of two cancer genes in reprogramming process” Read more »
Economist “Cancer may be caused by stem cells gone bad. If that proves to be correct, it should revolutionise treatment.” See related article – Shooting Down...
Scientific American, October 20, 2008 Read more »
The Scientist, October 17, 2008 Read more »
Newsweek, October 15, 2008 Read more »
San Francisco Business Times “Gov. Arnold Schwarzenegger vetoed SB 1565, aimed at making stem cell therapies and diagnostics funded by California's multibillion-dollar stem cell research agency...
Nature “The in vitro fertilization clinic Sydney IVF has received Australia’s first licence to conduct therapeutic cloning.” Read more »
HarvardScience “A team of Harvard Stem Cell Institute (HSCI) scientists has taken an important step towards producing induced pluripotent stem (iPS) cels that are safe to...
View press release »
Open Letter from ISSCR “The ISSCR Joined with other leading scientists today to issue an open letter to reiterate the urgent need for U.S. support for...
Nature “Kyoto University in Japan has acquired the world’s first patent for induced pluripotent stem (iPS) cells.” Read more »
Wired Science “Barack Obama has established a small but well-regarded inner circle of science advisors that includes Nobel laureates.” Read more »
The Boston Globe “Stem Cell research was one issue that many observers thought would fly under the radar in this year’s presidential election.” Read more »
Economist “A theory linking the scourge to stem cells may offer new ways of treating this most terrifying of diseases.” See related article – The Root...
Science, News “The announcement last week that a closely watched phase III clinical trial for Alzheimer’s disease had failed to show a significant effect deals yet...
View press release »
NYSCF hails Dr. Douglas Melton’s announcement that he and colleagues at the Harvard Stem Cell Institute have turned adult pancreatic cells into insulin-producing beta cells in...
Wired Science “The transformation of pancreas cells from one type to another has been hailed as a breakthrough: until now, such tricks required of scientifically —...
View press release »
HarvardScience “GlaxoSmithKline (GSK) and Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique...
View Press Release »
View press release »
New York Social Diary, August 2008 Read more »
Panache, August 2008 Read more »
The Los Angeles Times, August 1, 2008 Read more »